Overview

UI-EWD for Endoscopic Hemostasis of Bleeding Peptic Ulcers and Bleeding After EMR/ESD

Status:
Completed
Trial end date:
2017-09-18
Target enrollment:
Participant gender:
Summary
UI-EWD (NextBiomedical Co, Incheon, South Korea), a new hemostatic powder for endoscopic treatment of high-risk bleeding peptic ulcers and bleeding after ESD/EMR. Several endoscopic hemostasis methods are currently in use. UI-EWD (Endoscopic Wound Dressing) is adhesive absorbable powder as a new hemostasis material, the therapeutic effect and safety in endoscopic application will be verified. This study has been designed to observe comparing UI-EWD versus the submucosal epinephrine injection for endoscopic hemostasis of bleeding peptic ulcers and bleeding after EMR/ESD.
Phase:
N/A
Details
Lead Sponsor:
Next Biomedical Co., Ltd.
Treatments:
Epinephrine
Epinephryl borate
Racepinephrine